CTRI/2019/07/020156尚未招募未知
Evaluation of Thrombolytic action of Jalaukavacharana in portal vein thrombosis secondary to Liver cirrhosis. A randomised single arm open labeled clinical study
RGUHS0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Subjects fulfilling the diagnostic criteria.
- •1) Subjects aged between 20-60 years irrespective of gender, religion will be selected.
- •2) Subjects Fit for Raktamokshana through Jaloukavacharana
- •3) Subjects having Normal INR values
排除标准
- •1)Subjects suffering from systemic disorders which would interfere with present study.
- •2)Subjects suffering from Portal Vein thrombosis arising due to malignant causes
- •3)Patient with Ascitis.
- •4)Surgical emergencies.
研究者
相似试验
进行中（未招募）
1 期
Study to evaluate the safety and thrombolytic effect of increasing doses of DS9231 in sujbects with severe pulmonary embolismEUCTR2017-000552-25-HUDaiichi Sankyo Inc.104
已完成
不适用
Assessment of anti-thrombotic effects of conventional anti-thrombotic therapy using total thrombus-formation analysis system in transcatheter aortic valve replacementAortic stenosisJPRN-UMIN000041165Teikyo University120
已完成
2 期
Platenza Tablets for Dengue feverCTRI/2018/02/011789The Himalaya Drug Company40
尚未招募
不适用
Thrombolytic efficacy of intravenous recombinant tissue plasminogen activator with different dosesDiseases of the nervous systemKCT0000933Yonsei University Health System, Severance Hospital32
已完成
2 期
Platenza Tablets for Dengue feverCTRI/2018/03/012738The Himalaya Drug Company60